In summary, NIR FLIM FRET microscopy can be used to evaluate TZM‐HER2 drug‐target engagement, opening new avenues for advancing our understanding of TZM uptake and intracellular trafficking in HER2 positive cancer cell lines with distinct HER2 intracellular distributions. This evidence concerns the gene ERBB2 and cancer.